Smerud Medical Research, Specialists in cost-effective, client-focused and flexible proof-of-concept and pivotal regulatory trials.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Smerud Medical Research, Specialists in cost-effective, client-focused and flexible proof-of-concept and pivotal regulatory trials.
Released on: August 08, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Founder and CEO of Smerud Medical Research, Knut Smerud talks to Fintan Walton about the contract research organisation (CRO) company's proof-of-concept clinical trials and pivotal regulatory trials (phase IIb and III).
  • Summary
  • Transcript
  • Participants
  • Company
Founder and CEO of Smerud Medical Research, Knut Smerud talks to Fintan Walton about the contract research organisation (CRO) company's proof-of-concept clinical trials and pivotal regulatory trials (phase IIb and III). As well as how they help their clients to run cost-efficient clinical development programmes.
Founder and CEO of Smerud Medical Research, Knut Smerud talks to Fintan Walton about the contract research organisation (CRO) company's proof-of-concept clinical trials and pivotal regulatory trials (phase IIb and III). As well as how they help their clients to run cost-efficient clinical development programmes.
Knut Smerud
Smerud Medical Research
Smerud Medical Research
Smerud Medical Research is a contract research organisation (CRO) specialising in proof-of-concept clinical trials and pivotal regulatory trials (phase IIb and III). We help our clients to run cost-efficient clinical development programmes. OUR PRIMARY EXPERTISE Pivotal clinical development programmes Proof-of-concept studies Dose-response studies Phase IIIa therapeutic confirmatory studies Biometrics In-house data management and biostatistics unit Regulatory affairs Marketing authorisation applications including local translation and harmonisation of texts Clinical trial applications Pharmacovigilance Medical writing Quality assurance Site audits In-house audits Development of standard operating procedures Training courses Investigator-initiated trials Administrative support (e.g. applications, protocol writing, reporting) Quality control Data management and statistics Fundraising / grant applications For more information, please see our Services page. OUR APPROACH Smerud's trial management is cost-effective, client-focused and flexible - allowing intimate control over study progress. Our innovative study designs are aimed at exploiting scarce funding for early phase trials, employing expert strategy consultation and implementation. We adhere to agreed targets with dedication and reliability; and present the resulting data accurately and comprehensively. OUR PEOPLE Smerud's enthusiastic team is highly educated, particularly in scientific, medical and pharmaceutical fields. The group boasts strong expertise in pharmacology, physiology, medicine, biology, biochemistry, nursing and medical administration. This is derived from specific experience working with international pharmaceutical and biotechnology companies; multinational contract research organisations; academic research companies; and medical and research charities. All employees are trained to the industry guidelines for Good Clinical Practice (GCP). These guidelines are reflected in the company's standard operating procedures (SOPs).